Literature DB >> 19581000

High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort.

M D Seftel1, A A Demers, V Banerji, S B Gibson, C Morales, G Musto, M W Pitz, J B Johnston.   

Abstract

Incidence and outcomes of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) are not well established at the population level, especially since the widespread use of immunophenotyping. We studied the epidemiology of CLL in Manitoba (Canada) by combining data from a centralized flow cytometry facility and the provincial cancer registry for the period 1998-2003. Of 616 cases identified, 27% of patients identified by flow cytometry were not on the cancer registry. The age-adjusted incidence of 7.99/100,000 is substantially higher than the reported incidence in registry reports. We also noted differences in relative survival based on age and gender.

Entities:  

Mesh:

Year:  2009        PMID: 19581000     DOI: 10.1016/j.leukres.2009.06.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  17 in total

1.  Descriptive analysis of dosing and outcomes for patients with ibrutinib-treated relapsed or refractory chronic lymphocytic leukemia in a Canadian centre.

Authors:  K Uminski; K Brown; O Bucher; I Hibbert; D H Dhaliwal; J B Johnston; M Geirnaert; D E Dawe; V Banerji
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

2.  Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada.

Authors:  William Herring; Isobel Pearson; Molly Purser; Hamid Reza Nakhaipour; Amin Haiderali; Sorrel Wolowacz; Kavisha Jayasundara
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

3.  Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario.

Authors:  S Hassan; S J Seung; M C Cheung; G Fraser; B Kuriakose; C Trambitas; N Mittmann
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

Review 4.  Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.

Authors:  Clive S Zent; Neil E Kay
Journal:  Leuk Lymphoma       Date:  2011-06-08

5.  Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.

Authors:  Timothy G Call; Aaron D Norman; Curtis A Hanson; Sara J Achenbach; Neil E Kay; Clive S Zent; Wei Ding; James R Cerhan; Kari G Rabe; Celine M Vachon; Emily J Hallberg; Tait D Shanafelt; Susan L Slager
Journal:  Cancer       Date:  2014-04-07       Impact factor: 6.860

Review 6.  A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia.

Authors:  S Lachance; A L Christofides; J K Lee; L H Sehn; B C Ritchie; C Shustik; D A Stewart; C L Toze; E Haddad; D C Vinh
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

7.  Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Susan L Slager; Yolanda Benavente; Aaron Blair; Roel Vermeulen; James R Cerhan; Adele Seniori Costantini; Alain Monnereau; Alexandra Nieters; Jacqueline Clavel; Timothy G Call; Marc Maynadié; Qing Lan; Christina A Clarke; Tracy Lightfoot; Aaron D Norman; Joshua N Sampson; Delphine Casabonne; Pierluigi Cocco; Silvia de Sanjosé
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

8.  Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.

Authors:  Gregory A Abel; Kimberly A Bertrand; Craig C Earle; Francine Laden
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

9.  Updates from the American Society of Hematology 2019 annual meeting: practice-changing studies in treatment-naïve chronic lymphocytic leukemia.

Authors:  V Banerji; P Anglin; A Christofides; S Doucette; P Laneuville
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

10.  Using the SEER-Medicare Data to Assess Incident Chronic Myeloid Leukemia and Bladder Cancer Cases Missed by Cancer Registries.

Authors:  Clara J K Lam; Joan L Warren; Matthew Nielsen; Angela Smith; Eric Boyd; Michael J Barrett; Angela B Mariotto
Journal:  J Natl Cancer Inst Monogr       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.